In the past few years a number of reports have appeared describing the conditions in which there is an elevation of circulating y-glutamyl transpeptidase (GGT) (eg, Goldbarg, Pineda, Smith, Friedman, and Rutenburg, 1963; Orlowski, 1963; Zein and Discombe, 1970; Rosalki, Rau, Lehmann, and Prentice, 1970) . The level of this enzyme has been shown to be raised mainly in patients with liver disease and to a lesser extent in a number of other conditions, not apparently involving the liver (Table   I) . It (1967) Table I Diseases in which serum GGT has been found to be raised tidase is a useful enzyme to measure in serum in the assessment of liver disease, particularly when this is due to alcoholism or malignant infiltration (Zein and Discombe, 1970) . In view of the considerable number of enzymic tests for liver disease already available, Received for publication 18 July 1972. an additional one is unlikely to gain widespread acceptance unless it offers advantages either clinically or technically over existing tests.
In this paper, we describe a critical study of the value of GGT in the diagnosis and assessment of a group of 160 unselected patients undergoing investigation at Hammersmith Hospital. In these patients we compare GGT with two well established markers of hepatic parenchymal cell damage (aspartate transaminase, AST, and isocitrate dehydrogenase, ICD) and two biliary tract enzymes (alkaline phosphatase, ALP, and 5'-nucleotidase, 5NT). We have also assessed the diagnostic sensitivity of GGT in 81 of the 160 patients who were shown to have a definite liver disorder. Serial studies of liver enzymes were undertaken in selected patients in an attempt to determine whether the relative value of GGT compared with that of other enzymes varies with the stage of the disorder as described previously for AP and 5NT (Phelan, Neale, and Moss, 1970 GGT ALP 0-659 3-1 x 10-9 GGT = 2-00 ALP -039
GGT SNT 0-760 1-4 x 10-8 GOT = 1-50 SNT + 057
GGT AST 0 053 0-27 GGT ICD 0.079 0-11 ALP 5NT 0-713 3.0 x 10-9 5NT = 1.17 ALP -037 AST ICD 0-500 1-5 x 10-' ICD = 017 AST + 1-09 Table IV Correlations between enzyme results and  regression equations correlations between pairs of enzymes, not including GGT, which are accepted as giving similar information about the nature of pathological processes in the liver have also been calculated. The correlation coefficients between GGT and ALP or 5NT (r = 0-66 and 0.76 respectively) are of the same magnitude as that which relates ALP and 5NT (r = 0.71), two enzymes which respond similarly in intra-or extrahepatic biliary obstruction. On the other hand, the correlation between serum GGT and AST or ICD, enzymes which reflect hepatocellular damage, is not significant. The correlation between AST and ICD is itself highly significant but with a lower correlation coefficient (r = 0.50) than that between the pairs of 'biliary function' enzymes.
Serum GGT was raised in a higher proportion of the samples represented in Figs In 22 serum samples from 13 patients an elevated serum GGT activity was the only enzyme abnormality. The most common diagnosis in this group was alcoholic liver disease (five patients), followed by resolving viral hepatitis (four), and active chronic hepatitis (two). Diagnoses of cardiac failure and gallstones, respectively, were made in the two remaining cases. Case 1 (J.M., Fig. 5 ) A 42-year-old publican was admitted to hospital following a period of several months during which he had been drinking two bottles of brandy a day. On admission he was jaundiced and had marked oedema ITIS and ascites. He was given a low salt diet, thiazide diuretics, and spironolactone. His condition improved rapidly over the next month with clearance of the jaundice and fluid retention. Initially GGT was more markedly raised than ALP or 5NT. After four weeks' abstention from alcohol, GGT had fallen progressively to about the same level as the other two enzymes. Liver biopsy showed evidence of florid alcoholic cirrhosis. Serial studies in this patient demonstrated the disproportionately marked elevation of GGT found in many patients with alcoholic liver disease who have recently been taking alcohol.
Case 2 (A. W., Fig. 6 ) An 84-year-old retired man was admitted to hospital \ with a short history ofjaundice following a period of epigastric pain over the previous six months. The biochemical studies favoured a diagnosis of obstruc--o tive jaundice and two weeks later laparotomy was performed. The patient was found to have a carcinoma at the head of the pancreas and the obstruc-I ted common bile duct was bypassed by performing ,--cholecystoduodenostomy. Serial enzyme studies 40 showed disproportionately high GGT compared with ALP and 5NT, and a rapid fall to normal values immediately after the operation. This indicates the sensitivity of GGT and also demonstrates that the normal half life of the enzyme in the circulation is of the order of hours rather than of days.
Case 3 (J.V., Fig. 7) A 24-year-old housewife suffered an acute febrile illness consisting of hepatitis, renal failure, and a period of marrow hypoplasia. She presented initially with pyrexia and symptoms suggestive of a urinary tract infection which was treated with short courses of ampicillin, tetracycline, and finally trimethoprimsulphamethoxazole. She remained pyrexial and developed mild jaundice with raised levels of circulating hepatic enzymes. Two weeks after the start of her illness, she became uraemic and oliguric, and one week later was found to be anaemic (haemoglobin 6.8 g/100 ml) with pancytopaenia. The bone marrow was shown to be profoundlyhypoplastic. The patient made a complete recovery without further treatment. In these three cases serum GGT responds in a way that is broadly similar to ALP and 5NT, but with a greater degree of abnormality than either of these enzymes. These observations again suggest that the greater sensitivity of serum GGT as a liver function test, compared with ALP and 5NT, reflects a quantitative, rather than a qualitative, difference in behaviour in liver disease. 
SERUM GGT IN NON-HEPATOBILIARY CONDITIONS
The 10 patients with osteoblastic bone disease but with no evidence of liver disease all had normal GGT and 5NT values, whereas serum ALP was elevated on each occasion on which enzyme measurements were made. However, the group of 49 patients who were receiving phenobarbitone and/or phenytoin for the treatment of epilepsy had significantly higher serum GGT levels than a control group of 34 patients who were not receiving these drugs (Fig. 8) . The mean value and range of GGT activity for the treated group was 31 (0-125) iu/l, compared with 7 (0-25) iu/l for the controls. The difference between the means was significant at the 0.001 level.
Discussion
The strong correlation between serum GGT and ALP or 5NT in liver disease confirms that changes in the activity of GGT reflect principally alterations in biliary function, rather than damage to the parenchymal cells. The possible diagnostic advantages of serum GGT estimations are therefore to be considered in relation to measurements of ALP and 5NT.
An immediately obvious advantage of GGT is its greater sensitivity than either of the other two enzymes, of which 5NT is probably the next in order of sensitivity (Phelan et al, 1971 ). On these grounds, therefore, GGT would be the enzyme of choice if ± 9-2 at a level of 68 iu/l (n = 28) for the measurement of 5NT. However, two considerations caution against the use of GGT alone for the detection of liver disease. The first of these is the lack of specificity for hepatobiliary disease: although some of the changes in serum GGT listed in Table I may be attributable to secondary liver disease, this cannot be assumed in every case. Changes in 5NT, on the other hand, seem to be confined exclusively to hepatobiliary disease and, while bone, intestine, and placenta can contribute to an increased serum ALP, the organ specificity of this enzyme also can be increased by isoenzyme characterization. The second consideration concerns the effect of certain drugs in raising the serum GGT, possibly as a result of induction of the enzyme in the liver. The range and nature of those drugs which can produce this effect are not well defined at present, nor whether an increased serum GGT is an invariable consequence of their administration, and a raised serum GGT unsupported by other chemical or clinical abnormalities in a patient who has been receiving medication should therefore be interpreted with caution. This limitation erodes some of the clinical value of the sensitivity of GGT assays. Enzyme induction may also account for the marked elevations of serum GGT activity in patients with alcoholic liver disease which was noted in the present study as well as by earlier workers (Zein and Discombe, 1970) . In hepatobiliary disease due to other causes, some factor associated with biliary retention may stimulate production of hepatic GGT, which is normally present in small amounts only (Orlowski, 1963) , in the way that biliary obstruction is now believed to result in synthesis of hepatic alkaline phosphatase de novo (Kaplan and Righetti, 1970) .
Our conclusions are that serum GGT is a valuable diagnostic aid when used in conjunction with ALP assays for the investigation of latent or chronic liver disease. The use of serum GGT measurements in this way can largely replace 5NT, except when the possibility of renal disease, recent myocardial infarction or, most importantly, a history of drug administration, are present to make the interpretation of serum GGT levels doubtful.
